How to select a cell biology journal
Start with the biological question, experimental system, and readers who should use the result. Molecular mechanisms, organelles, signaling, imaging, stem cells, and developmental systems can call for different journals even when they converge on the same cellular process.
Match quantitative methods and translational cell biology to journals whose current scope supports both the approach and the paper's central biological advance.
Treat the three groups as an editorial fit shortlist, not a ranking or prediction of acceptance. Confirm the live scope, article type, evidence requirements, and author instructions before submitting.
Manuscript type matrix
Start with the manuscript's main contribution, then compare audience and article-type fit before using journal metrics.
| Manuscript type | Prioritize | Avoid when |
|---|---|---|
| Molecular mechanisms | Prioritize: A journal whose readers will value the molecular mechanism, its causal evidence, and the general cell-biological principle it reveals. | Avoid when: The evidence remains correlative or the molecular detail is not connected to a cellular function or broader principle. |
| Organelles and trafficking | Prioritize: Readers focused on organelle biogenesis, dynamics, contacts, membrane trafficking, proteostasis, and spatial organization inside cells. | Avoid when: The organelle phenotype is descriptive and lacks a mechanism, functional consequence, or clear advance over established localization data. |
| Cell signaling | Prioritize: A journal aligned with the pathway, cellular context, signal dynamics, and physiological or disease consequence established by the study. | Avoid when: The paper catalogs pathway changes without causal perturbation, temporal logic, or a supported downstream cellular outcome. |
| Imaging | Prioritize: A cell-biology readership that can use the imaging advance or the biological insight enabled by microscopy, image analysis, or spatial measurement. | Avoid when: Image quality or scale substitutes for a biological question, appropriate controls, quantitative analysis, or independent validation. |
| Stem cells | Prioritize: Readers studying stemness, cell fate, lineage decisions, niches, organoids, regeneration, disease models, and cell-based translation. | Avoid when: Stem cells are only an experimental source and the main conclusion does not advance stem-cell or regenerative biology. |
| Developmental systems | Prioritize: A journal that values mechanistic links among cell behavior, morphogenesis, lineage, tissue organization, development, and regeneration. | Avoid when: The work describes a developmental phenotype without resolving the cellular mechanism or transferable biological lesson. |
| Quantitative methods | Prioritize: A journal receptive to quantitative cell biology, modeling, bioengineering, tools, or resources that enable reproducible biological discovery. | Avoid when: The method lacks benchmarking, accessible implementation, biological validation, or utility beyond one narrowly optimized experiment. |
| Translational cell biology | Prioritize: Readers who can connect a rigorous cellular mechanism to disease, therapeutic response, tissue function, or a credible translational application. | Avoid when: The disease association is observational or the translational claim extends beyond the cellular and functional evidence. |
Reach journals
Consider these when the study delivers an unusually deep mechanistic advance with broad conceptual importance across cell biology or neighboring disciplines. Field-wide reach is a fit signal, not evidence of easier acceptance.
CELL
Cell Press
- 2026 Impact Factor
- 45.1
- JCR quartile
- Q1
- 2025 publication volume
- 509
- Median submission-to-acceptance
- 296 days
- n=99 · 99% coverage
Suitable for
- • Transformative mechanisms across experimental biology
- • Findings with broad conceptual importance
- • Deep evidence connecting molecules, cells, and systems
Why it may fit
Transformative mechanistic biology with broad conceptual importance across disciplines.
Caution
Field-wide significance and unusually deep evidence are expected.
NATURE CELL BIOLOGY
Nature Portfolio
- 2026 Impact Factor
- 22.7
- JCR quartile
- Q1
- 2025 publication volume
- 273
- Median submission-to-acceptance
- 339 days
- n=70 · 70% coverage
Suitable for
- • Fundamental cell-biological mechanisms
- • Organelle organization, trafficking, and signaling
- • Development, stem cells, and advanced imaging
Why it may fit
Major advances in cell mechanisms, organization, signaling, development, and imaging.
Caution
A complete mechanistic story is more important than descriptive scale.
Molecular Cell
Elsevier BV
- 2026 Impact Factor
- 16.0
- JCR quartile
- Q1
- 2025 publication volume
- 366
- Median submission-to-acceptance
- 217 days
- n=99 · 99% coverage
Suitable for
- • Gene regulation and genome organization
- • Signaling, metabolism, and cell-cycle mechanisms
- • Molecular systems with general biological insight
Why it may fit
Deep molecular mechanisms in gene regulation, signaling, metabolism, and cellular systems.
Caution
Connect molecular detail to a clear general principle.
Cell Stem Cell
Elsevier BV
- 2026 Impact Factor
- 23.3
- JCR quartile
- Q1
- 2025 publication volume
- 161
- Median submission-to-acceptance
- 194.5 days
- n=100 · 100% coverage
Suitable for
- • Stemness, lineage, and developmental biology
- • Regeneration, organoids, and disease models
- • Cell-based therapeutic and translational studies
Why it may fit
Stem-cell biology, development, regeneration, disease models, and cell-based translation.
Caution
Stemness or regenerative biology must be central rather than incidental.
Strong-match journals
These can be the strongest destination when the manuscript offers a substantial mechanistic advance for molecular, cellular, developmental, imaging, or quantitative audiences. A more focused readership is not an easier acceptance path.
EMBO JOURNAL
Springer Nature
- 2026 Impact Factor
- 8.4
- JCR quartile
- Q1
- 2025 publication volume
- 330
- Median submission-to-acceptance
- 182 days
- n=100 · 100% coverage
Suitable for
- • Mechanistic molecular and cell biology
- • Physiologically relevant biological advances
- • Conceptual findings that reach beyond one specialty
Why it may fit
Mechanistic molecular and cell biology with broad conceptual relevance.
Caution
Show a clear advance beyond a specialized observation.
DEVELOPMENTAL CELL
Elsevier BV
- 2026 Impact Factor
- 9.2
- JCR quartile
- Q1
- 2025 publication volume
- 260
- Median submission-to-acceptance
- 290.5 days
- n=100 · 100% coverage
Suitable for
- • Cell mechanisms in development and regeneration
- • Morphogenesis, polarity, migration, and tissue organization
- • Stem-cell, lineage, and cell-fate studies
Why it may fit
Cell biology linked to development, morphogenesis, organization, and tissue systems.
Caution
Pure developmental description without mechanism may not fit.
Cell Reports
Cell Press
- 2026 Impact Factor
- 7.7
- JCR quartile
- Q1
- 2025 publication volume
- 1,576
- Median submission-to-acceptance
- 185.5 days
- n=100 · 100% coverage
Suitable for
- • Well-supported molecular and cell biology findings
- • Focused reports with new biological insight
- • Resources with substantial biological value
Why it may fit
Substantial, well-supported findings across molecular and cell biology.
Caution
Broad publication volume is not evidence of easy acceptance.
JOURNAL OF CELL BIOLOGY
Rockefeller University Press
- 2026 Impact Factor
- 6.1
- JCR quartile
- Q2
- 2025 publication volume
- 289
- Median submission-to-acceptance
- 217 days
- n=84 · 84% coverage
Suitable for
- • Cellular mechanisms, organelles, and trafficking
- • Cytoskeleton, imaging, and quantitative biology
- • Tools with broad value and biological insight
Why it may fit
Rigorous cell mechanisms, organelles, cytoskeleton, trafficking, imaging, and quantitative biology.
Caution
Strong mechanistic and visual evidence is usually important.
Broader-scope journals
These journals can fit rigorous cell mechanisms, imaging, development, quantitative tools, resources, or translational work when their current readership and article type align. Broader scope does not mean easy acceptance; evidence quality and editorial fit still matter.
JOURNAL OF CELL SCIENCE
The Company of Biologists
- 2026 Impact Factor
- 3.9
- JCR quartile
- Q3
- 2025 publication volume
- 398
- Median submission-to-acceptance
- 141 days
- n=73 · 73% coverage
Suitable for
- • Cell signaling, organelles, and membrane trafficking
- • Imaging, cytoskeleton, and mechanobiology
- • Development, differentiation, and model-system biology
Why it may fit
Cell mechanisms, imaging, organelles, signaling, development, and model-system biology.
Caution
Explain the general cell-biological lesson beyond one model.
MOLECULAR BIOLOGY OF THE CELL
American Society for Cell Biology
- 2026 Impact Factor
- 3.0
- JCR quartile
- Q3
- 2025 publication volume
- 226
- Median submission-to-acceptance
- Not enough public date data
Suitable for
- • Fundamental molecular and cellular mechanisms
- • Quantitative and physical cell biology
- • Reproducible tools, methods, and resources
Why it may fit
Fundamental cellular mechanisms, quantitative studies, tools, and reproducible cell biology.
Caution
Match the contribution to the journal's core cell-biology readership.
Life Science Alliance
Publisher not available
- 2026 Impact Factor
- 3.1
- JCR quartile
- Q2
- 2025 publication volume
- 167
- Median submission-to-acceptance
- 164.5 days
- n=100 · 100% coverage
Suitable for
- • Complete molecular and cellular studies
- • Genomic, resource, and methods papers
- • Translational work with reusable evidence
Why it may fit
Solid molecular, cellular, genomic, and translational studies with reusable evidence.
Caution
Confirm that the paper offers a complete advance, not only preliminary data.
Biology Open
The Company of Biologists
- 2026 Impact Factor
- 1.8
- JCR quartile
- Q3
- 2025 publication volume
- 226
- Median submission-to-acceptance
- 47 days
- n=93 · 93% coverage
Suitable for
- • Rigorous mechanistic and imaging studies
- • Developmental and organismal biology
- • Transparent, well-supported biological findings
Why it may fit
Sound mechanistic, imaging, developmental, and organismal biology with transparent evidence.
Caution
Broader-scope positioning does not predict acceptance.
Journals receiving a first JIF in 2026
Explore newer metric entrants separately, then return to manuscript fit when building the final submission shortlist.
See the cell biology first-JIF analysis →Test the shortlist against your research
Compare manuscript fit with AI or examine the literature around your research topic in PubMed.
Methodology and limits
Broader-scope does not mean easy acceptance. There is no comprehensive acceptance-rate data for these journals, and the metrics on this page do not predict acceptance.
Publication volume uses OpenAlex works from the complete 2025 calendar year. OpenAlex works are not submissions or acceptances, so output describes publishing scale rather than editorial selectivity.
Timing uses qualified PubMed received-to-accepted date pairs from the fixed 2024–2025 window. It is a historical median, not a forecast. Missing date data is not evidence of speed, and unqualified journals are shown as “Not enough public date data.”
Confirm each journal's current scope, article types, author instructions, indexing, fees, and policies before submission.
Frequently asked questions
Should a molecular mechanism, stem-cell study, or developmental system go to the same journal?
Not necessarily. Start with the paper's central inference and the readers who should use it. A molecular mechanism may fit a journal centered on core cellular pathways, while a study in which stemness, lineage, morphogenesis, or regeneration is central may be stronger in a stem-cell or cell-and-development journal.
Should a basic cell biology paper target a translational journal?
Choose a translational venue when disease relevance, therapeutic mechanism, biomarker, or clinical path is central and supported. Choose a core cell-biology journal when the main advance is a general cellular mechanism demonstrated with mechanistic depth.
Does higher publication volume mean a cell biology journal is easier to enter?
No. The 2025 OpenAlex publication volume describes recent output, not an acceptance rate or editorial threshold. Use it to understand publishing scale only, then evaluate scope, conceptual advance, mechanistic depth, evidence quality, and audience fit.
What does the PubMed submission-to-acceptance timing mean?
The timing is a median calculated only for journals with qualified coverage of paired received and accepted dates in PubMed records. It is descriptive historical context, not a promise for a new submission or a substitute for the journal's current guidance.
How does the first-JIF analysis complement this guide?
The linked first-JIF analysis examines cell biology journals receiving a first Journal Impact Factor in the 2026 release. Use it to explore newer metric entrants, then return here to compare established shortlist options by manuscript fit.
Related Articles
Best Neurosurgery Journals 2026: IF, Volume & Timing
Compare neurosurgery journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readJournal Submission GuideBest Ophthalmology Journals 2026: IF, Volume & Timing
Compare ophthalmology journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readJournal Submission GuideBest Bioinformatics Journals 2026: IF, Volume & Timing
Compare bioinformatics journals by Impact Factor 2026, 2025 publication volume, submission-to-acceptance timing, and manuscript fit.
16 min readTake the next research step
Compare manuscript fit with AI or examine the literature around your research topic in PubMed.
Canonical article: https://www.journalmetrics.org/blog/best-cell-biology-journals